HANGZHOU, China, Aug. 26, 2024 /PRNewswire/ — Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK), a leading player in China’s peripheral and neurovascular intervention markets, today announced its interim financial results for 2024. The Company reported revenue of $51.26 million, a…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.